The goals of this project are: (a) to identify the regions of the vWF molecule which are responsible for its binding to platelets, to collagen, and to proteoglycans; (b) to determine the 3-dimensional structure of these binding domains; and (c) to characterize the molecular mechanism responsible for binding of vWF to its ligands. Functional domains on the vWF molecule will be identified and characterized by proteolytic fragmentation of the vWF, by chemical and enzymatic modification of vWF, and by use of monoclonal antibodies which inhibit specific functions of vWF. The structure of these fragments will be determined by preparing and sequencing the cDNA for bovine vWF, by amino acid sequencing of fragments, and by physical studies of these fragments. Complementary domains on the platelet receptor for vWF will also be prepared by proteolytic fragmentation of platelet membrane glycoprotein Ib. Mechanisms of interaction will be defined by preparation of synthetic peptide analogs of binding domains and examining their binding to vWF and glycoprotein Ib.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Temple University
Schools of Medicine
United States
Zip Code
Sinha, D; Bakhshi, M R; Vora, R K et al. (1996) Engineering DNA and protein chimeras utilizing coding sequences of restriction sites. Anal Biochem 238:205-8
Bakhshi, M R; Sinha, D; Vora, R K et al. (1996) Primary binding domain of bovine von Willebrand factor fragment expressed in E. coli. Thromb Haemost 75:196-202
Janel, N; Schwachtgen, J L; Bakhshi, M R et al. (1995) Comparison of the 5'-flanking sequences of the human and bovine von Willebrand factor-encoding genes reveals alternation of highly homologous domains with species-specific Alu-type repeats. Gene 167:291-5
Sinha, D; Yang, X; Emig, F et al. (1994) Isolation and characterization of two protease inhibitors from bovine plasma. J Biochem 115:387-91
Sinha, D; Bakhshi, M; Vora, R (1994) Ligand binding assays with recombinant proteins refolded on an affinity matrix. Biotechniques 17:509-12, 514
Sinha, D; Bakhshi, M; Kunapuli, S et al. (1994) ASP514 within the A1 domain of bovine von Willebrand factor is required for interaction with platelet glycoprotein Ib. Biochem Biophys Res Commun 203:881-8
Peng, M; Lu, W; Beviglia, L et al. (1993) Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood 81:2321-8
Bakhshi, M R; Myers, J C; Howard, P S et al. (1992) Sequencing of the primary adhesion domain of bovine von Willebrand factor. Biochim Biophys Acta 1132:325-8
Peng, M; Lu, W; Kirby, E P (1992) Characterization of three alboaggregins purified from Trimeresurus albolabris venom. Thromb Haemost 67:702-7
Peng, M; Lu, W; Kirby, E P (1991) Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein Ib. Biochemistry 30:11529-36

Showing the most recent 10 out of 16 publications